journal article Mar 01, 2011

Learning lessons from Pfizer's $800 million failure

Nature Reviews Drug Discovery Vol. 10 No. 3 pp. 163-164 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/nrd3401

Topics

No keywords indexed for this article. Browse by subject →

References

3

[1]

Br. J. Pharmacol. (2008) 10.1038/bjp.2008.229

[2]

N. Engl. J. Med. (2007) 10.1056/nejmoa0706628

[3]

N. Engl. J. Med. (2010) 10.1056/nejmoa1009744

Metrics

21

Citations

3

References

Details

Published: Mar 01, 2011
Vol/Issue: 10(3)
Pages: 163-164
License: View

Cite This Article

(2011). Learning lessons from Pfizer's $800 million failure. Nature Reviews Drug Discovery, 10(3), 163-164. https://doi.org/10.1038/nrd3401

Related

You May Also Like

Engineering precision nanoparticles for drug delivery

Michael J. Mitchell, Margaret M. Billingsley · 2020

6,594 citations

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Dunyaporn Trachootham, Jérôme Alexandre · 2009

4,706 citations

Recent advances with liposomes as pharmaceutical carriers

Vladimir P. Torchilin · 2005

4,409 citations

Natural products in drug discovery: advances and opportunities

Atanas G. Atanasov, Sergey B. Zotchev · 2021

4,371 citations

Drug repurposing: progress, challenges and recommendations

Sudeep Pushpakom, Francesco Iorio · 2018

3,975 citations